[1] Worldometers (2020) COVID-19 Coronavirus Pandemic.
https://www.worldometers.info/coronavirus
[2] Vitacca, M., Nava, S., Santus, P., et al. (2020) Early Consensus Management for Non-ICU ARF SARS-CoV-2 Emergency in Italy: From Ward to Trenches. European Respiratory Journal.
https://doi.org/10.1183/13993003.00632-2020
[3] Sustainable Development Goals [Website]. United Nations, New York.
https://sustainabledevelopment.un.org/topics/sustainabledevelopmentgoals
[4] Thwaites, G.E., van Toorn, R. and Schoeman, J. (2013) Tuberculous Meningitis: More Questions, Still Too Few Answers. The Lancet Neurology, 12, 999-1010.
https://doi.org/10.1016/S1474-4422(13)70168-6
[5]
https://github.com/CSSEGISandData/COVID-19
[6] Près de 30.000 cas de tuberculose sont enregistrés chaque année au Maroc, y compris les nouveaux cas et les cas de rechute.
https://www.medias24.com/30-000-cas-de-tuberculose-chaque-annee-au-maroc-1101.html
[7] Katti, M.K. (2004) Pathogenesis, Diagnosis, Treatment, and Outcome Aspects of Cerebral Tuberculosis. Medical Science Monitor, 10, RA215-RA229.
[8] Kent, S.J., Crowe, S.M., Yung, A., Lucas, C.R. and Mijch, A.M. (1993) Tuberculous Meningitis: A 30-Year Review. Clinical Infectious Diseases, 17, 987-994.
https://doi.org/10.1093/clinids/17.6.987
[9] Boyles, T.H. and Thwaites, G.E. (2015) Appropriate Use of the Xpert(R) MTB/RIF Assay in Suspected Tuberculous Meningitis. International Journal of Tuberculosis and Lung Disease, 19, 276-277.
https://doi.org/10.5588/ijtld.14.0805
[10] Bahr, N.C., Marais, S., Caws, M., et al. (2016) Tuberculous Meningitis International Research C: GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test But Not the Last. Clinical Infectious Diseases, 62, 1133-1135.
https://doi.org/10.1093/cid/ciw083
[11] Panteleev, A.V., Nikitina, I.Y., Burmistrova, I.A., Kosmiadi, G.A., Radaeva, T.V., Amansahedov, R.B., et al. (2017) Severe Tuberculosis in Humans Correlates Best with Neutrophil Abundance and Lymphocyte Deficiency and Does Not Correlate with Antigen-Specific CD4 T-Cell Response. Frontiers in Immunology, 8, 963.
https://doi.org/10.3389/fimmu.2017.00963
[12] Lin, W. and Chen, P. (2020) Tubercular Meningitis in Patients with Systemic Lupus Erythematosus: Clinical Characteristics, Risk Factors, and Outcomes of 10 Patients. Clinical Rheumatology, 39, 1141-1145.
https://doi.org/10.1007/s10067-020-04940-9
[13] Pathak, S., Wentzel-Larsen, T. and Åsjö, B. (2010) Effects of in Vitro HIV-1 Infection on Mycobacterial Growth in Peripheral Blood Monocyte-Derived Macrophages. Infection and Immunity, 78, 4022-4032.
https://doi.org/10.1128/IAI.00106-10
[14] Whittaker, E., López-Varela, E., Broderick, C. and Seddon, J.A. (2019) Examining the Complex Relationship between Tuberculosis and Other Infectious Diseases in Children. Frontiers in Pediatrics, 7, 233.
https://doi.org/10.3389/fped.2019.00233
[15] Melzer, M., Brown, T., Flood, J., Lacey, S. and Bagg, L. (1999) False Negative Polymerase Chain Reaction on Cerebrospinal Fluid Samples in Tuberculous Meningitis Established by Culture. Journal of Neurology, Neurosurgery and Psychiatry, 67, 249-250.
https://doi.org/10.1136/jnnp.67.2.249a
[16] (2014) Recommandation de la Société de pneumologie de langue française sur la prise en charge de la tuberculose en France.
http://www.sp2a.fr/pdf/document/recommandations-prise-en-charge-tuberculose-france,108-.html
[17] American Thoracic Society, Center for Disease Control and Prevention, Infectious Disease Society of America (2003) Treatment of Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 167, 603-662.
https://doi.org/10.1164/rccm.167.4.603
[18] Marais, S., Thwaites, G., Schoeman, J.F., Török, M.E., Misra, U.K., Prasad, K., et al. (2010) Tuberculous Meningitis: A Uniform Case Definition for Use in Clinical Research. The Lancet Infectious Diseases, 10, 803-812.
https://doi.org/10.1016/S1473-3099(10)70138-9
[19] Visca, D., Zampogna, E., Sotgiu, G., Centis, R., Saderi, L., D’Ambrosio, L., Pegoraro, V., Pignatti, P., Muňoz-Torrico, M., Migliori, G.B. and Spanevello, A. (2019) Pulmonary Rehabilitation Is Effective in Patients with Tuberculosis Pulmonary Sequelae. European Respiratory Journal, 53, Article ID: 1802184.
https://doi.org/10.1183/13993003.02184-2018
[20] Visca, D., Tiberi, S., Pontali, E., Spanevello, A. and Migliori, G.B. (2020) Tuberculosis in the Time of COVID-19: Quality of Life and Digital Innovation. European Respiratory Journal, 56, Article ID: 2001998.
https://doi.org/10.1183/13993003.01998-2020